期刊文献+

肠道微生物群在肝细胞癌发病机制中的作用 被引量:8

Role of intestinal microflora in the pathogenesis of hepatocellular carcinoma
下载PDF
导出
摘要 肝细胞癌(HCC)是最常见的原发性肝癌,是慢性肝病的并发症之一。最近的实验和临床研究表明,肠-肝轴的改变在慢性肝病(包括HCC)的发病中起关键作用。肠道微生物群的改变越来越被认为是促进慢性肝病进展为HCC的关键因素。总结了与HCC相关的肠道微生物菌群变化的最新发现,并讨论了肠道微生物群对HCC发生发展的重要意义。 Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is one of the complications of chronic liver diseases. Recent experimental and clinical studies have shown that the gut-liver axis plays a key role in the pathogenesis of chronic liver diseases including HCC. Change in intestinal microflora is considered the key factor for the progression of chronic liver diseases to HCC. This article summarizes the latest research advances in changes in intestinal microflora associated with HCC and discusses the importance of intestinal microflora in the development and progression of HCC.
作者 郑微 张永宏 赵艳 ZHENG Wei;ZHANG Yonghong;ZHAO Yan(Clinical Laboratory Center,Beijing YouAn Hospital,Capital Medical University,Beijing 100069,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2019年第7期1613-1615,共3页 Journal of Clinical Hepatology
基金 北京市医院管理局重点医学专业发展计划(ZYLX201711) 北京市医院管理局“登峰”人才培养计划(DFL20181701) 传染病相关疾病生物标志物北京市重点实验室(BZ0373)
关键词 肠-肝轴 肝肿瘤 胃肠道微生物组 intestinal hepatic axis liver neoplasms gastrointestinal microbiome
  • 相关文献

参考文献5

二级参考文献55

  • 1Dimitrios Dimitroulis,Serena Valsami,Eleftherios Spartalis,Emmanuel Pikoulis,Gregory Kouraklis.Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus[J].World Journal of Hepatology,2013,5(6):323-327. 被引量:4
  • 2吴仲文,徐凯进,李兰娟,左键,盛吉芳,郑树森,梁廷波,沈岩,王伟林,张珉.78例肝硬化患者肠道细菌易位及其相关性研究[J].中华外科杂志,2006,44(21):1456-1459. 被引量:16
  • 3Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907-1917.
  • 4Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the fork- head family transcription factor Foxp3. Nat Immunol 2005; 6: 331-337.
  • 5Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T. Immunologic tolerance maintained by CD25+ CD4+ regula- tory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance, lmmunol Rev 2001; 182:18-32.
  • 6Nishikawa H, Sakaguchi S. Regulatory T cells in tumor im- munity. Int J Cancer 2010; 127:759-767.
  • 7Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck- Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003; 9:606-612.
  • 8Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A. CD4+CD25+ regulatory T cells in patients with gastrointesti- nal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 2003; 98:1089-1099.
  • 9Schaefer C, Kim GG, Albers A, Hoermann K, Myers EN, Wh- iteside TL. Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br J Cancer 2005; 92:913-920.
  • 10Khazaie K, von Boehmer H. The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer. Semin Cancer Bio12006; 16:124-136.

共引文献65

同被引文献72

引证文献8

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部